We demonstrate for the first time that reovirus therapy of BrCa leads to the augmentation of NF-kB gene transcription and identify PUMA as a novel, direct NF-kB driven target of reovirus mediated oncolyis. Here, NFKB1 is linked to invasive breast carcinoma.